Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose
Clinical trial NCT06428903 · COMPLETED
Trial details
- NCT number
- NCT06428903
- Sponsor
- Jiaxing AnDiCon Biotech Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2024-09-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.